Clinical Scorecard: Association of Plasma Atherogenic Index with Erectile Dysfunction: Findings from a Cross-Sectional Observational Study
At a Glance
Category
Detail
Condition
Erectile Dysfunction (ED)
Key Mechanisms
Endothelial dysfunction and atherosclerosis leading to impaired penile blood flow and reduced nitric oxide bioavailability
Target Population
Adult sexually active men presenting to urology clinic
Care Setting
Urology outpatient clinic
Key Highlights
ED shares risk factors with coronary artery disease and may precede clinical cardiovascular disease due to smaller penile artery size.
Atherogenic Index of Plasma (AIP), reflecting small dense LDL-C particles, is associated with atherosclerosis and endothelial dysfunction implicated in ED.
No significant differences in lipid profiles or atherogenic indices were observed between men with and without ED in this cross-sectional study.
Guideline-Based Recommendations
Diagnosis
Assess erectile function using the International Index of Erectile Function (IIEF-5) questionnaire.
Exclude secondary causes of ED such as endocrine disorders, neurological conditions, and medication effects.
Evaluate lipid profiles including triglycerides, HDL-C, and calculate Atherogenic Index of Plasma (AIP) for atherosclerotic risk assessment.
Management
Address modifiable cardiovascular risk factors including dyslipidemia, diabetes, and smoking.
Consider lifestyle modifications to improve endothelial function and reduce atherosclerotic progression.
Pharmacologic treatment of ED should consider underlying vascular health.
Monitoring & Follow-up
Regular follow-up of lipid profiles and cardiovascular risk markers in men with ED.
Monitor erectile function using validated questionnaires to assess treatment response.
Risks
ED may be an early indicator of systemic atherosclerosis and increased cardiovascular risk.
Medications such as diuretics and beta blockers may worsen ED and should be reviewed.
Patient & Prescribing Data
Adult men with and without erectile dysfunction attending urology clinic
No significant differences in lipid or atherogenic indices were found between ED and non-ED groups, suggesting multifactorial etiology and need for comprehensive cardiovascular risk management.
Clinical Best Practices
Use IIEF-5 for standardized assessment of erectile function.
Exclude secondary causes and medications that may affect erectile function before attributing ED to vascular causes.
Incorporate lipid profile and atherogenic indices like AIP in cardiovascular risk assessment for men with ED.
Educate patients on the link between ED and cardiovascular health to promote adherence to lifestyle and medical interventions.
by Ali Riza Turkoglu, Yasemin Ustundag, Akif Koç, Murat Ozturk, Anil Erkan, Atilla Satir, Oğuzhan Akpinar, Muhammet Guzelsoy, Abdullah Gul, Soner Coban
